You have no items in your shopping cart.
RecombinantVEGF-C,Human [orb1494619]> 95% as analyzed by SDS-PAGE.
16~19 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg- RecombinantTSG,His,Human [orb1494621]
> 95% as analyzed by SDS-PAGE and HPLC.
30-33 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg - RecombinantRANTES/CCL5,Human(HEK293-expressed) [orb1494625]
> 98% as analyzed by SDS-PAGE.
8 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg >95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. a single, non-glycosylated, polypeptide chain containing 157 amino acids fragment (77-233) and having a molecular mass of 21.85 kDa with an amino-terminal hexahistidine tag.
Escherichia coli.
1 mg, 10 μg, 50 μg>95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. The recombinant protein preparation is a mixture of a 158 amino acid residue form containing an N-terminal methionine and a 157 amino acid residue form with the sequence of mature human TNF-α.
Escherichia coli.
1 mg, 10 μg, 50 μg- Recombinant Human Interleukin-2 (rHuIL-2) [orb1495078]
>97% by SDS-PAGE and HPLC analyses.
Approximately 15 kDa, a single non-glycosylated polypeptide chain containing 134 amino acids.
Escherichia coli.
1 mg, 10 μg, 50 μg - Recombinant Human Epidermal Growth Factor ( rHuEGF ) [orb1495084]
>98% by SDS-PAGE and HPLC analyses.
6222 Da, a single non-glycosylated polypeptide chain containing 53 amino acids.
Escherichia coli.
1 mg, 100 μg, 500 μg - RecombinantENA78/CXCL5(9-78a.a.),Human [orb1494890]
> 95% as analyzed by SDS-PAGE.
7.7 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantENA-78/CXCL5(5-78aa),Human [orb1494891]
> 95% as analyzed by SDS-PAGE
8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
5 μg, 25 μg, 1 mg - RecombinantEGF,Rat [orb1494892]
> 95% by SDS-PAGE analysis.
6.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 20 μg, 100 μg